InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
2
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+11.9%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the detailed record of transactions filed by Choi Jung. Insider active across 2 companies, notably Global Blood Therapeutics, Inc.. In total, 12 filings have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €119k. Activity tracked since 31 August 2021. The latest transaction was filed on 1 December 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Choi Jung
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
12 条申报中的 12 条
About Choi Jung
Choi Jung is a declarant linked to Annexon, Inc. as Director, and to Global Blood Therapeutics, Inc. with the role listed as See Remarks. The profile covers 12 filings, with buys totaling EUR 119183 and no sells in the sampled filings between 2016-01-07 and 2025-12-03, and the most frequent transaction nature is option exercise.
